The proposed research will characterize interactions between monoamine transporter inhibitors and cocaine in nonhuman primate models of i.v. drug self-administration, neuroimaging with positron emission tomography (PET) and functional magnetic resonance imaging (fMRI), and in vivo microdialysis. Emphasis will be directed toward combined inhibition of the dopamine transporter (DAT) and the serotonin transporter (SERT) in the context of cocaine self-administration. A second-order schedule of i.v. drug self-administration in rhesus monkeys will be used to evaluate the effectiveness of combined inhibition of DAT and SERT to reduce cocaine self-administration, and to maintain self-administration when substituted for cocaine (Aim 1). Similarly, extinction conditions will be used to evaluate the effectiveness of combined inhibition of DAT and SERT to attenuate cocaine-induced reinstatement, and to induce reinstatement in the absence of cocaine (Aim 2). PET neuroimaging techniques will be used to quantify DAT and SERT occupancy at drug doses shown to be effective in drug self-administration and reinstatement studies (Aim 3). In addition, in vivo microdialysis techniques will be used to correlate DAT and SERT occupancy measures with drug-induced changes in dopamine, serotonin and their primary metabolites (Aim 4). Lastly, fMRI protocols will be implemented in awake, behaving monkeys in order to characterize functional changes in CNS activity during self- administration of cocaine or selective DAT inhibitors. Studies conducted during the previous funding period documented the effectiveness of selective DAT inhibitors to reduce or eliminate cocaine self-administration, but only at high levels of DAT occupancy. Moreover, selective DAT inhibitors reliably maintained drug self- administration and induced reinstatement of extinguished cocaine self-administration behavior. It is hypothesized that combined inhibition of DAT and SERT will lower the level of DAT occupancy required to reduce cocaine self-administration, and limit the reinforcing and reinstatement effects of DAT inhibitors. It is also hypothesized that selective DAT inhibitors will induce a pattern of brain activation similar to that observed for cocaine. In contrast, combined inhibition of DAT and SERT will limit brain activation induced by cocaine and DAT inhibitors, and by drug-associated stimuli. Collectively, the integration of behavioral pharmacology, functional neuroimaging and in vivo neurochemistry will enhance our understanding of the neurobiological mechanisms involved in cocaine self-administration and reinstatement in nonhuman primates. The results obtained will also evaluate the effectiveness of monoamine transporters as potential targets for cocaine medications development.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37DA010344-14
Application #
7812185
Study Section
Neurobiology of Motivated Behavior Study Section (NMB)
Program Officer
Aigner, Thomas G
Project Start
1997-08-15
Project End
2011-04-30
Budget Start
2010-05-01
Budget End
2011-04-30
Support Year
14
Fiscal Year
2010
Total Cost
$493,114
Indirect Cost
Name
Emory University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Berro, Laís F; Shields, Hannah; Odabas-Geldiay, Melis et al. (2018) Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) and R(-) MDMA on actigraphy-based daytime activity and sleep parameters in rhesus monkeys. Exp Clin Psychopharmacol 26:410-420
Berro, Laís F; Andersen, Monica L; Howell, Leonard L (2017) Assessment of tolerance to the effects of methamphetamine on daytime and nighttime activity evaluated with actigraphy in rhesus monkeys. Psychopharmacology (Berl) 234:2277-2287
Berro, Laís F; Perez Diaz, Maylen; Maltbie, Eric et al. (2017) Effects of the serotonin 2C receptor agonist WAY163909 on the abuse-related effects and mesolimbic dopamine neurochemistry induced by abused stimulants in rhesus monkeys. Psychopharmacology (Berl) 234:2607-2617
Berro, Laís F; Andersen, Monica L; Tufik, Sergio et al. (2017) GABAA receptor positive allosteric modulators modify the abuse-related behavioral and neurochemical effects of methamphetamine in rhesus monkeys. Neuropharmacology 123:299-309
Berro, Laís F; Andersen, Monica L; Tufik, Sergio et al. (2016) Actigraphy-based sleep parameters during the reinstatement of methamphetamine self-administration in rhesus monkeys. Exp Clin Psychopharmacol 24:142-6
Murnane, K S; Gopinath, K S; Maltbie, E et al. (2015) Functional connectivity in frontal-striatal brain networks and cocaine self-administration in female rhesus monkeys. Psychopharmacology (Berl) 232:745-54
Howell, Leonard L; Cunningham, Kathryn A (2015) Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder. Pharmacol Rev 67:176-97
Howell, Leonard L; Negus, S Stevens (2014) Monoamine transporter inhibitors and substrates as treatments for stimulant abuse. Adv Pharmacol 69:129-76
Howell, L L; Nye, J A; Stehouwer, J S et al. (2014) A thermostable bacterial cocaine esterase rapidly eliminates cocaine from brain in nonhuman primates. Transl Psychiatry 4:e407
McIntosh, Scot; Howell, Leonard; Hemby, Scott E (2013) Dopaminergic dysregulation in prefrontal cortex of rhesus monkeys following cocaine self-administration. Front Psychiatry 4:88

Showing the most recent 10 out of 35 publications